Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations.
about
Inhibition of phosphoinositide 3-kinase/Akt pathway decreases hypoxia inducible factor-1α expression and increases therapeutic efficacy of paclitaxel in human hypoxic gastric cancer cellsA genetic model for gallbladder carcinogenesis and its dissemination.Combination of celecoxib and PD184161 exerts synergistic inhibitory effects on gallbladder cancer cell proliferation.Inactivation of tumor suppressor gene pten in early and advanced gallbladder cancerProhibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition.DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer.Initial analysis of peripheral lymphocytic extracellular signal related kinase activation in autism.Phenoxodiol enhances the antitumor activity of gemcitabine in gallbladder cancer through suppressing Akt/mTOR pathway.Role of aberrant PI3K pathway activation in gallbladder tumorigenesis.Biliary cancer: intrahepatic cholangiocarcinoma vs. extrahepatic cholangiocarcinoma vs. gallbladder cancers: classification and therapeutic implications.Insulin/Insulin-Like Growth Factor-1 Pathway in Barrett's CarcinogenesisMTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma.Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.Prognostic values of ERK1/2 and p-ERK1/2 expressions for poor survival in non-small cell lung cancer.Lentivirus‑mediated MDA7/IL24 expression inhibits the proliferation of hepatocellular carcinoma cells.A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks.Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico.
P2860
Q28384554-37F96396-F569-4BF1-ADAD-93751AE0144AQ33683102-78BC620E-0555-4125-B3D9-22A401CADD44Q33684263-F8578BD7-E9BE-43AD-9592-0FB5FFE05D4BQ35986673-E9E7324E-5116-4EEB-9378-C6C23B79EDD9Q36804624-C9C7ABD3-DEE9-423D-919F-0C37EADA52D7Q36899519-02770F66-16EE-4D1E-81CC-9B134BE9FBA6Q37707060-38629553-DC9A-462E-955A-430ADF343307Q38811433-780273CD-B840-4BA5-BC77-C7D638A8DA86Q38987927-148EE2F1-818D-462B-9E49-8196CA8F9D52Q39285469-F4C527D1-D487-4C6F-B62A-31B79DC71B0CQ39289707-D495D8AF-88CE-4F74-BB1C-AAC61B3FE5CCQ39561604-CE955FEB-1E21-48DC-BBD5-39ACA4159FE1Q44671372-F514EC0E-2A8B-41A4-AD13-B3928873DF03Q50178323-D07C45B6-221F-4488-83AA-8DD49405BA00Q51666148-8448B0CB-F928-432E-AF32-9BEA527C1A39Q52683985-5051B724-3D11-41D3-81D2-EA7EAF1538B2Q52900022-85C235B9-AEB6-4519-ABB5-D6CF6CB04932Q55481891-9AE10BDD-1999-4B90-ADF6-31A96F6AD472
P2860
Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression of phospho-ERK1/2 a ...... and pathological correlations.
@en
Expression of phospho-ERK1/2 a ...... and pathological correlations.
@nl
type
label
Expression of phospho-ERK1/2 a ...... and pathological correlations.
@en
Expression of phospho-ERK1/2 a ...... and pathological correlations.
@nl
prefLabel
Expression of phospho-ERK1/2 a ...... and pathological correlations.
@en
Expression of phospho-ERK1/2 a ...... and pathological correlations.
@nl
P2860
P356
P1476
Expression of phospho-ERK1/2 a ...... and pathological correlations.
@en
P2093
Qinglong Li
Zhulin Yang
P2860
P2888
P356
10.1186/1756-9966-28-65
P577
2009-05-18T00:00:00Z
P5875
P6179
1006001170